Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SRC | P12931 | 1/20 | 0.37 |
| ▸ | GAA | P10253 | 1/20 | 0.35 |
| ▸ | SRD5A1 | P18405 | 2/20 | 0.33 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.33 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.33 |
| ▸ | MEN1 | O00255 | 1/20 | 0.32 |
| ▸ | POLB | P06746 | 1/20 | 0.32 |
| ▸ | MAPT | P10636 | 1/20 | 0.32 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.32 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.32 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11667005 | 0.81 | TTR (0.42) | GAAKMT2A | |
| SCHEMBL2142447 | 0.79 | KDM4E (0.42) | SRCKDM4E | |
| SCHEMBL3801608 | 0.79 | KDM4E (0.42) | SRCKDM4E | |
| SCHEMBL7656115 | 0.78 | GABRA1 (0.40) | SRCGAAMEN1POLBMAPT | |
| SCHEMBL30595265 | 0.78 | SRC (0.47) | SRCGAAL3MBTL1TDP1MAPT | |
| SCHEMBL1963991 | 0.77 | SRC (0.50) | SRCGAAL3MBTL1TDP1MAPT | |
| SCHEMBL31585711 | 0.77 | SRC (0.50) | SRCGAAL3MBTL1TDP1MAPT | |
| SCHEMBL5605199 | 0.77 | SRC (0.50) | SRCGAAL3MBTL1TDP1MAPT | |
| SCHEMBL7660203 | 0.76 | CNR1 (0.38) | — | |
| SCHEMBL7781174 | 0.76 | GABRA1 (0.41) | GAASRD5A1MEN1MAPTMAPK1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6479688-B2 | FROM REACTING TERT-BUTYLHYDROQUINONE AND MONOPHENYL DICHLOROPHOSPHATE IN PRESENCE OF ACID CATALYST; FLAME RETARDANTS | AKZO NOBEL NV (NL) | 2002-11-12 | — | — | US | disclosed |
| US-6479688-B2 | FROM REACTING TERT-BUTYLHYDROQUINONE AND MONOPHENYL DICHLOROPHOSPHATE IN PRESENCE OF ACID CATALYST; FLAME RETARDANTS | AKZO NOBEL NV (NL) | 2002-11-12 | — | — | US | disclosed |
| US-20020151739-A1 | PROCESS FOR MAKING DI(HYDROXYALKYLARYL) ARYL PHOSPHATE COMPOUNDS | ICL-IP AMERICA INC. | 2002-10-17 | — | — | US | disclosed |
| US-20020151739-A1 | PROCESS FOR MAKING DI(HYDROXYALKYLARYL) ARYL PHOSPHATE COMPOUNDS | ICL-IP AMERICA INC. | 2002-10-17 | — | — | US | disclosed |
| US-6403819-B1 | REACTING ORTHO-ALKYL SUBSTITUTED AROMATIC DIOL AND MONOARYL DIHALOPHOSPHATE | AKZO NOBEL, NV (NL) | 2002-06-11 | — | — | US | disclosed |
| US-6403819-B1 | REACTING ORTHO-ALKYL SUBSTITUTED AROMATIC DIOL AND MONOARYL DIHALOPHOSPHATE | AKZO NOBEL, NV (NL) | 2002-06-11 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20020151739-A1 | PROCESS FOR MAKING DI(HYDROXYALKYLARYL) ARYL PHOSPHATE COMPOUNDS | GNPAT, DHODH, DDT | SRC 1254/4885GAA 504/4885SRD5A1 298/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.